IRCR-DReSS
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for IRCR-DReSS, covering 2022-06-15 to 2022-06-15. Get the full timeline:
Most recent: Clinical Trial Update: Exploratory Study of Drug Sensitivity Prediction Software (IRCR-DReSS) With Patient-derived Tumor Cells of Metastatic Gastric Cancer [Phase 2]